6.
Passaro R, Ramsey K, Segura E, Lake J, Reback C, Clark J
. Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depend. 2018; 195:164-169.
PMC: 6512788.
DOI: 10.1016/j.drugalcdep.2018.06.036.
View
7.
Hammond A, Sweeney M, Chikosi T, Stitzer M
. Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health. J Subst Abuse Treat. 2021; 126:108425.
PMC: 8197772.
DOI: 10.1016/j.jsat.2021.108425.
View
8.
Landovitz R, Fletcher J, Shoptaw S, Reback C
. Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infect Dis. 2015; 2(1):ofu114.
PMC: 4396429.
DOI: 10.1093/ofid/ofu114.
View
9.
Reback C, Veniegas R, Shoptaw S
. Getting Off: development of a model program for gay and bisexual male methamphetamine users. J Homosex. 2013; 61(4):540-53.
DOI: 10.1080/00918369.2014.865459.
View
10.
Li M, Su E, Garland W, Oksuzyan S, Lee S, Kao U
. Trajectories of Viral Suppression in People Living With HIV Receiving Coordinated Care: Differences by Comorbidities. J Acquir Immune Defic Syndr. 2020; 84(4):387-395.
PMC: 7327135.
DOI: 10.1097/QAI.0000000000002351.
View
11.
Naji L, Dennis B, Rosic T, Wiercioch W, Paul J, Worster A
. Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 2022; 232:109295.
DOI: 10.1016/j.drugalcdep.2022.109295.
View
12.
Strona F, McCright J, Hjord H, Ahrens K, Tierney S, Shoptaw S
. The acceptability and feasibility of the Positive Reinforcement Opportunity Project, a community-based contingency management methamphetamine treatment program for gay and bisexual men in San Francisco. J Psychoactive Drugs. 2007; Suppl 3:377-83.
DOI: 10.1080/02791072.2006.10400601.
View
13.
Silverman K, Holtyn A, Rodewald A, Siliciano R, Jarvis B, Subramaniam S
. Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical Trial. AIDS Behav. 2019; 23(9):2337-2346.
PMC: 6768703.
DOI: 10.1007/s10461-019-02592-8.
View
14.
Coffin P, Santos G, Hern J, Vittinghoff E, Walker J, Matheson T
. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial. JAMA Psychiatry. 2019; 77(3):246-255.
PMC: 6990973.
DOI: 10.1001/jamapsychiatry.2019.3655.
View
15.
Trivedi M, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T
. Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021; 384(2):140-153.
PMC: 8111570.
DOI: 10.1056/NEJMoa2020214.
View
16.
Maxwell S, Shahmanesh M, Gafos M
. Chemsex behaviours among men who have sex with men: A systematic review of the literature. Int J Drug Policy. 2018; 63:74-89.
DOI: 10.1016/j.drugpo.2018.11.014.
View
17.
Li M, Chau B, Belin T, Carmody T, Jha M, Marino E
. Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Addiction. 2024; 119(10):1840-1845.
PMC: 11436298.
DOI: 10.1111/add.16529.
View
18.
Blair C, Gandhi M, Shoptaw S, Blades C, Clark J
. Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment. AIDS Behav. 2022; 27(6):1962-1971.
PMC: 10152513.
DOI: 10.1007/s10461-022-03929-6.
View
19.
Shoptaw S, Li M, Javanbakht M, Ragsdale A, Goodman-Meza D, Gorbach P
. Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles. Drug Alcohol Depend. 2022; 232:109320.
PMC: 8885921.
DOI: 10.1016/j.drugalcdep.2022.109320.
View
20.
Gorbach P, Javanbakht M, Ragsdale A, Bolan R, Flynn R, Mandler R
. Methamphetamine Injection Among Young Men Who Have Sex With Men: Risk for Human Immunodeficiency Virus Transmission in a Los Angeles Cohort. J Infect Dis. 2020; 222(Suppl 5):S471-S476.
PMC: 7566619.
DOI: 10.1093/infdis/jiz610.
View